CHELSEA LETTIERI: Open Payments
NPI 1942716386 · FLOURTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,956 in 141 payments from 20 companies in 2025. Trend: 2023 $2,600 · 2024 $2,741 · 2025 $2,956
Food & beverage: $2,750Education: $206
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $576 |
| ABBVIE INC. | 27 | $430 |
| LEO Pharma Inc. | 18 | $302 |
| Lilly USA, LLC | 11 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $218 |
| GENZYME CORPORATION | 7 | $216 |
| Novartis Pharmaceuticals Corporation | 8 | $158 |
| Galderma Laboratories, L.P. | 10 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ADBRY, COSENTYX, TALTZ, ILUMYA, RINVOQ.
Industry payments across PA — which companies pay providers there.
